MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing Search

Search the Innovaro Pharmalicensing out-licensing directory by keyword. Alternatively our advanced search allows you to query by industry sector, therapeutic target and development phase.
 
Industry sector Therapeutic target
Development phase
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Most Viewed

Each Dose of Neo-Penotran® contains a combination of Metronidazole and Miconazole Nitrate in therapeutic concentrations for the local treatment of the treatment three main types of vaginal infections and mixed forms of vaginitis. More
New cream formulation to manage the symptoms of atopic dermatitis. More
Collagen-based dressings for wound management More
5 and 10 mg Donepezil as well as 4 and 8 mg Ondansetron are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
25 and 50 mg diclofenac K film coated immediate release tablets More

Recently Added

nanovesicle delivery systems, delivery of oxygen reactive compounds, antioxidant, anti-inflammatory treatment, superoxide dismutase / SOD, drug delivery More
We have developed NUBIScan, a computer algorithm to predict DNA recognition sites for NRs in the regulatory regions of genes More
Sulfoglycolipids, T-cell lymphocytes, CD1, 2-palmitoyl-3-hydroxyphthioceranoyl-2'-sulfate-a,a'-D-trehalose, M. tuberculosis More
Interventional Magnetic Resonance Imaging, Navigation, Hall, Interventional devices More
Pharmaceutically active monoclonal antibody, human melanocortin-4 receptor (MC4R), treatment of weight loss, anorexia / cachexia, modulation of appetite and food intake, compositions including such mAbs or binding fragments thereof More

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us